Biocon Announcements
Extra-Ordinary General Meeting scheduled to be held on Wednesday, December 31, 2025
07 Dec, 2025 | 02:17pm • Source: BSE
Outcome of Board Meeting - Raising of Funds through issuance of Commercial Papers
06 Dec, 2025 | 11:29am • Source: BSE
Outcome of Board Meeting - Raising of funds by way of issuance of any instrument or security in one or mode permissible modes
06 Dec, 2025 | 11:24am • Source: BSE
Outcome of Board Meeting - Preferential Issue
06 Dec, 2025 | 11:18am • Source: BSE
Outcome of Board Meeting - Increase in Authorised Share Capital and consequential amendment to the Memorandum of Association of the Company
06 Dec, 2025 | 10:58am • Source: BSE
Outcome of Board Meeting-Acquisition
06 Dec, 2025 | 10:54am • Source: BSE
Investor Presentation
06 Dec, 2025 | 10:44am • Source: BSE
Intimation of schedule of analyst call and presentation for the same under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
06 Dec, 2025 | 10:41am • Source: BSE
Press Release
06 Dec, 2025 | 10:16am • Source: BSE
Outcome of Board Meeting under Regulation 30 of SEBI Listing Regulations, 2015
06 Dec, 2025 | 10:12am • Source: BSE
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
05 Dec, 2025 | 03:42pm • Source: BSE
Biocon Limited has informed the Exchange regarding a press release dated December 02, 2025, titled "Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in...
02 Dec, 2025 | 09:47am • Source: NSE
Press Release
02 Dec, 2025 | 09:10am • Source: BSE
Biocon Limited has informed the Exchange regarding Company Statement.
27 Nov, 2025 | 10:28am • Source: NSE
Audio and Video Recording of Q2 FY26 Earnings Call
12 Nov, 2025 | 03:17pm • Source: BSE